Testosterone Low-T Lawsuit

• AndroGel (AbbVie, formerly a division of Abbott Laboratories)
  Testosterone therapy gel applied directly to the skin.
• AndroDerm (Actavis plc, formerly known as Watson Pharmaceuticals, Inc.)
  Testosterone treatment patch or film that delivers medication through the skin.
• Axiron (Eli Lilly and Company)
  Testosterone therapy gel which is applied to the armpits.
• Bio-T-Gel (GlaxoSmithKline plc)
  Testosterone treatment gel that is applied to the skin.
• Delatestryl (Savient Pharmaceuticals, Inc.)
  Injectable testosterone drug.
• Depo-Testosterone (Pfizer, Inc.)
  Injectable testosterone pharmaceutical.
• Fortesta (Endo Pharmaceuticals, Inc.)
  Testosterone spray gel that is applied directly to the skin.
• Striant (Mipharm S.p.A. for Columbia Laboratories, Inc.)
  Time release testosterone tablet.
• Testim (Auxilium Pharmaceuticals, Inc.)
  Testosterone therapy gel that is applied to the skin.
• Testopel (Slate Pharmaceuticals, Inc.)
  Slow release testosterone implant that is inserted under the skin.

About Testosterone Therapy Medications

Testosterone therapy medications have been approved by the federal Food and Drug Administration (FDA) for treatment of men who have been diagnosed with hypogonadism, a medical condition in which the body fails to produce adequate levels of testosterone.  As a result of marketing campaigns directed to consumers, however, many physicians are prescribing testosterone drugs “off-label” to men who are experiencing only natural age-related declines in their testosterone production.  This illegal practice has resulted in an enormous growth in testosterone therapy sales for the benefit of manufacturers of the products.

Various claims are made for testosterone treatment drugs including assertions that they will improve sex drive and performance, produce increased muscle growth, reduce body fat and build stronger bones.

Medical research reveals, however, that men who use testosterone drugs are at a substantially greater risk of heart attack, stroke and death than are men who do not use the Low-T therapies.

Pending lawsuits against drug manufacturers allege, among others, that manufacturers failed to properly research the potential side effects of testosterone drugs, concealed critical information about their serious side effects, and improperly marketed these drugs to consumers.